Brad G Angeja, MD
Cardiovascular Disease (Cardiology) · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Angeja’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G87722 · Current
Licensed to practise in California · since 2006 · expires 2027-09-30 · Hahnemann University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$342,804
Medicare paid this office $342,804 for 2,743 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 353 | $69,367 | $190 |
| Return visit (30+ min) | 475 | $57,913 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 469 | $27,164 | $56 |
| Long return visit (40+ min) | 130 | $23,276 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $22,088 | $104 |
See all 37 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 353 | $69,367 | $190 |
| Return visit (30+ min) | 475 | $57,913 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 469 | $27,164 | $56 |
| Long return visit (40+ min) | 130 | $23,276 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $22,088 | $104 |
| Interpretation and report of ultrasound of heart | 132 | $14,870 | $76 |
| Critical care, first 30-74 minutes | 61 | $13,110 | $175 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 971 | $12,432 | $12 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 54 | $10,534 | $195 |
| New patient visit (45+ min) | 68 | $9,307 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 904 | $9,041 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $7,835 | $145 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $6,024 | $241 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 329 | $5,234 | $15 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 19 | $4,984 | $74 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 76 | $4,753 | $63 |
| Ultrasound of heart with probe in esophagus, with report | 46 | $4,398 | $94 |
| New patient visit (60+ min) | 20 | $3,598 | $180 |
| Ultrasound of heart, follow-up | 136 | $3,299 | $22 |
| Transitional care management services for problem of high complexity | 11 | $2,985 | $271 |
| Ultrasound of heart, follow-up | 26 | $2,713 | $97 |
| Ultrasound of heart blood flow, valves and chambers | 143 | $2,600 | $16 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, with interpretation and report | 75 | $2,291 | $31 |
| External shock to heart to regulate heart beat | 22 | $2,231 | $93 |
| 3d radiographic procedure | 46 | $1,231 | $26 |
| Heart muscle strain imaging | 26 | $1,044 | $39 |
| Short return visit (20+ min) | 13 | $1,027 | $79 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 74 | $872 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $839 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 31 | $816 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 214 | $753 | $3 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $529 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 68 | $451 | $6 |
| 3d radiographic procedure | 32 | $294 | $8 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 12 | $294 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 12 | $171 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $136 | $10 |
Who their Medicare patients are
2,743 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 23% · Women 51% · Also on Medicaid 11% · Health risk score 1.52. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Atrial fibrillation 38% · Diabetes 34% · Chronic kidney disease 33% · Heart failure 32% · Cancer 19% · Depression 18% · COPD 16% · Stroke 12% · Dementia 10%.
The office billed $1,578,061, Medicare allowed $457,925 and paid $342,804; for 6,286 services of 55 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,743 | 6,286 | 78 | 1.52 | $1,578,061 | $342,804 |
| 2023 | 2,470 | 5,028 | 78 | 1.39 | $1,334,784 | $301,246 |
| 2022 | 2,149 | 4,513 | 78 | 1.55 | $1,116,663 | $273,342 |
| 2021 | 1,983 | 4,955 | 77 | 1.52 | $1,460,733 | $370,170 |
| 2020 | 2,085 | 4,742 | 77 | 1.60 | $1,197,309 | $294,367 |
| 2019 | 2,009 | 5,398 | 77 | 1.60 | $1,834,140 | $423,400 |
| 2018 | 1,571 | 4,166 | 77 | 1.64 | $1,382,499 | $336,954 |
| 2017 | 1,430 | 4,259 | 77 | 1.76 | $1,469,887 | $366,739 |
| 2016 | 1,347 | 3,792 | 77 | 1.72 | $1,380,631 | $352,931 |
| 2015 | 1,330 | 4,282 | 77 | 1.73 | $1,368,283 | $366,515 |
| 2014 | 1,201 | 4,156 | 77 | 1.58 | $1,522,928 | $387,099 |
| 2013 | 1,179 | 3,958 | 77 | 1.68 | $1,675,448 | $428,403 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 38 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 347 | $68,284 | $192 |
| Return visit (30+ min) | 395 | $44,604 | $104 |
| Long return visit (40+ min) | 216 | $37,309 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 250 | $15,997 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,014 | $14,423 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $12,785 | $105 |
| Critical care, first 30-74 minutes | 60 | $12,652 | $183 |
| New patient visit (45+ min) | 62 | $8,543 | $138 |
| New patient visit (60+ min) | 46 | $8,302 | $180 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 34 | $7,609 | $224 |
| Interpretation and report of ultrasound of heart | 74 | $7,498 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 738 | $6,916 | $7 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 32 | $6,386 | $200 |
| Ultrasound of heart with probe in esophagus, with report | 47 | $4,749 | $93 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 66 | $4,426 | $67 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 21 | $4,139 | $57 |
| Ultrasound of heart, follow-up | 39 | $3,976 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,461 | $157 |
| External shock to heart to regulate heart beat | 25 | $2,575 | $95 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 36 | $2,248 | $62 |
| Ultrasound of heart blood flow, valves and chambers | 90 | $1,664 | $16 |
| Ultrasound of heart, follow-up | 68 | $1,602 | $22 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 21 | $1,578 | $22 |
| Short return visit (20+ min) | 20 | $1,338 | $67 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 48 | $1,229 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 44 | $1,157 | $26 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,022 | $57 |
| Heart muscle strain imaging | 21 | $781 | $37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 62 | $774 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 29 | $683 | $23 |
| 3d radiographic procedure | 20 | $471 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 139 | $464 | $3 |
| Heart rhythm recording of continous external ekg over 8-15 days | 30 | $406 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 49 | $320 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $213 | $19 |
| 3d radiographic procedure | 20 | $190 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $141 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $88 | $7 |
2022: 36 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 250 | $49,906 | $193 |
| Return visit (30+ min) | 370 | $44,133 | $107 |
| Long return visit (40+ min) | 201 | $37,223 | $152 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 215 | $14,053 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $12,531 | $91 |
| Critical care, first 30-74 minutes | 48 | $9,815 | $185 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 959 | $8,807 | $7 |
| New patient visit (60+ min) | 39 | $7,977 | $205 |
| Ultrasound of heart with probe in esophagus, with report | 65 | $7,465 | $94 |
| New patient visit (45+ min) | 49 | $7,420 | $151 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 525 | $7,284 | $13 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 30 | $6,109 | $204 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $5,792 | $241 |
| Interpretation and report of ultrasound of heart | 60 | $4,827 | $78 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 57 | $3,846 | $67 |
| Ultrasound of heart, follow-up | 28 | $3,191 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $2,315 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,305 | $177 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 33 | $2,074 | $63 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 22 | $1,814 | $23 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 23 | $1,642 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,409 | $67 |
| External shock to heart to regulate heart beat | 14 | $1,393 | $99 |
| Ultrasound of heart blood flow, valves and chambers | 82 | $1,388 | $16 |
| Ultrasound of heart, follow-up | 52 | $1,322 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 45 | $1,129 | $25 |
| Short return visit (20+ min) | 11 | $823 | $75 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 29 | $822 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 26 | $776 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 51 | $678 | $13 |
| Heart rhythm recording of continous external ekg over 8-15 days | 42 | $651 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $628 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 134 | $424 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 54 | $395 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $351 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $242 | $10 |
2021: 37 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 114 | $57,159 | $489 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 249 | $52,382 | $201 |
| Long return visit (40+ min) | 203 | $37,681 | $152 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 113 | $33,630 | $149 |
| Return visit (30+ min) | 224 | $25,913 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 278 | $18,442 | $64 |
| Injection, regadenoson, 0.1 mg | 83 | $15,805 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $14,225 | $92 |
| Critical care, first 30-74 minutes | 51 | $11,538 | $192 |
| Ultrasound of heart with probe in esophagus, with report | 71 | $8,156 | $97 |
| New patient visit (60+ min) | 37 | $7,492 | $202 |
| Interpretation and report of ultrasound of heart | 88 | $7,490 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 742 | $7,302 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 116 | $7,053 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,052 | $176 |
| Telephone medical discussion with physician, 11-20 minutes | 105 | $7,011 | $61 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $7,010 | $234 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 482 | $6,963 | $14 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 30 | $6,542 | $204 |
| New patient visit (45+ min) | 45 | $6,098 | $136 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $2,038 | $97 |
| Ultrasound of heart, follow-up | 18 | $2,005 | $106 |
| Ultrasound of heart, follow-up | 67 | $1,774 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 100 | $1,734 | $16 |
| External shock to heart to regulate heart beat | 15 | $1,605 | $100 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 18 | $1,577 | $23 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 18 | $1,482 | $21 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 39 | $966 | $25 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 41 | $780 | $19 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $720 | $65 |
| Heart rhythm recording of continous external ekg over 8-15 days | 37 | $588 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 165 | $554 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $554 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 68 | $531 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $528 | $28 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $446 | $34 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $235 | $11 |
2020: 34 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 97 | $48,422 | $494 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 197 | $40,222 | $198 |
| Return visit (30+ min) | 224 | $21,564 | $84 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 96 | $18,517 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $16,802 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 209 | $14,878 | $68 |
| Long return visit (40+ min) | 109 | $14,846 | $121 |
| Injection, regadenoson, 0.1 mg | 66 | $12,464 | None |
| Critical care, first 30-74 minutes | 46 | $11,833 | $194 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 602 | $9,841 | $16 |
| Telephone medical discussion with physician, 11-20 minutes | 122 | $9,349 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 890 | $9,172 | $8 |
| New patient visit (45+ min) | 48 | $6,969 | $145 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 99 | $6,118 | $62 |
| Interpretation and report of ultrasound of heart | 65 | $5,202 | $80 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $5,190 | $226 |
| New patient visit (60+ min) | 28 | $4,896 | $175 |
| Telephone medical discussion with physician, 21-30 minutes | 32 | $3,735 | $104 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,550 | $178 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 16 | $3,369 | $211 |
| Ultrasound of heart with probe in esophagus, with report | 31 | $3,092 | $97 |
| Short return visit (20+ min) | 41 | $2,405 | $59 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 18 | $1,879 | $22 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 19 | $1,778 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 80 | $1,397 | $16 |
| Ultrasound of heart, follow-up | 52 | $1,386 | $24 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | $1,118 | $43 |
| Ultrasound of heart, follow-up | 11 | $1,065 | $76 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 35 | $441 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 131 | $431 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 51 | $386 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $332 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $319 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $191 | $11 |
2019: 36 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 181 | $89,958 | $466 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $63,605 | $198 |
| Return visit (30+ min) | 302 | $35,777 | $90 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 180 | $35,188 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 378 | $26,946 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $24,202 | $93 |
| Injection, regadenoson, 0.1 mg | 127 | $23,429 | None |
| Critical care, first 30-74 minutes | 53 | $15,036 | $193 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 190 | $11,687 | $61 |
| Long return visit (40+ min) | 89 | $11,449 | $123 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 53 | $11,218 | $212 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 627 | $10,245 | $15 |
| New patient visit (45+ min) | 64 | $9,449 | $148 |
| Short return visit (20+ min) | 114 | $7,328 | $60 |
| Interpretation and report of ultrasound of heart | 69 | $5,806 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,341 | $181 |
| Ultrasound of heart with probe in esophagus, with report | 42 | $4,266 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 441 | $4,186 | $8 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 12 | $2,451 | $204 |
| Transitional care management services for problem of at least moderate complexity | 15 | $2,365 | $158 |
| Ultrasound of heart, follow-up | 82 | $2,310 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,164 | $66 |
| External shock to heart to regulate heart beat | 17 | $1,723 | $96 |
| Ultrasound of heart blood flow, valves and chambers | 94 | $1,714 | $16 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 19 | $1,523 | $21 |
| Ultrasound of heart, follow-up | 15 | $1,522 | $101 |
| New patient visit (30+ min) | 11 | $1,127 | $102 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 24 | $1,122 | $12 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,083 | $68 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 83 | $667 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 175 | $611 | $3 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 35 | $433 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $415 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $407 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $287 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $163 | $14 |
2018: 32 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 130 | $65,322 | $484 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 218 | $46,085 | $200 |
| Return visit (30+ min) | 309 | $38,358 | $89 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 128 | $24,472 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 297 | $20,721 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 106 | $19,867 | $92 |
| Long return visit (40+ min) | 113 | $16,258 | $119 |
| Injection, regadenoson, 0.1 mg | 72 | $12,700 | None |
| Critical care, first 30-74 minutes | 50 | $12,394 | $194 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 54 | $11,711 | $217 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $8,203 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 480 | $7,538 | $15 |
| New patient visit (45+ min) | 42 | $5,420 | $129 |
| Short return visit (20+ min) | 71 | $4,617 | $63 |
| Interpretation and report of ultrasound of heart | 51 | $4,251 | $80 |
| Ultrasound of heart with probe in esophagus, with report | 41 | $4,200 | $98 |
| New patient visit (60+ min) | 22 | $4,103 | $186 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,817 | $174 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 16 | $3,231 | $202 |
| External shock to heart to regulate heart beat | 17 | $1,795 | $100 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 168 | $1,519 | $7 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 28 | $1,501 | $12 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 23 | $1,461 | $21 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,423 | $65 |
| Ultrasound of heart, follow-up | 53 | $1,406 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 74 | $1,284 | $16 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 18 | $1,277 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 123 | $900 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 127 | $424 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 52 | $392 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $293 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $219 | $11 |
2017: 31 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 184 | $93,122 | $478 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $36,957 | $219 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 184 | $35,208 | $95 |
| Return visit (30+ min) | 275 | $33,902 | $87 |
| Injection, regadenoson, 0.1 mg | 125 | $21,690 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $20,224 | $92 |
| Critical care, first 30-74 minutes | 60 | $16,521 | $194 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 257 | $15,686 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 186 | $12,197 | $65 |
| Long return visit (40+ min) | 70 | $10,536 | $120 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $7,777 | $259 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,395 | $180 |
| New patient visit (60+ min) | 31 | $5,585 | $180 |
| Ultrasound of heart with probe in esophagus, with report | 43 | $5,395 | $98 |
| New patient visit (45+ min) | 36 | $5,208 | $145 |
| Short return visit (20+ min) | 70 | $4,418 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 250 | $4,215 | $15 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 18 | $3,628 | $202 |
| Interpretation and report of ultrasound of heart | 27 | $2,250 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 218 | $1,971 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 226 | $1,714 | $7 |
| External shock to heart to regulate heart beat | 14 | $1,603 | $100 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 17 | $1,113 | $22 |
| Ultrasound of heart, follow-up | 43 | $1,071 | $23 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $1,066 | $67 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 23 | $1,019 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 52 | $960 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $380 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 95 | $334 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 43 | $302 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $174 | $13 |
2016: 29 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 170 | $89,092 | $498 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 208 | $47,351 | $222 |
| Return visit (30+ min) | 275 | $35,633 | $90 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 172 | $33,323 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $16,410 | $92 |
| Injection, regadenoson, 0.1 mg | 89 | $15,193 | None |
| Long return visit (40+ min) | 96 | $13,527 | $123 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 171 | $11,470 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 188 | $11,458 | $57 |
| Critical care, first 30-74 minutes | 50 | $10,820 | $193 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $8,058 | $260 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,580 | $165 |
| Short return visit (20+ min) | 101 | $6,677 | $61 |
| New patient visit (45+ min) | 35 | $5,218 | $149 |
| New patient visit (60+ min) | 28 | $5,031 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 266 | $4,425 | $15 |
| Ultrasound of heart with probe in esophagus, with report | 37 | $4,244 | $109 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 50 | $3,337 | $67 |
| Interpretation and report of ultrasound of heart | 23 | $2,105 | $92 |
| Transitional care management services for problem of at least moderate complexity | 12 | $1,885 | $157 |
| External shock to heart to regulate heart beat | 16 | $1,803 | $106 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 226 | $1,683 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 146 | $1,357 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 46 | $782 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $708 | $64 |
| External ekg recording for more than 48 hours up to 21 days | 16 | $474 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 16 | $409 | $24 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 13 | $403 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 58 | $179 | $3 |
2015: 29 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 168 | $90,225 | $534 |
| Return visit (30+ min) | 311 | $45,872 | $97 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 169 | $44,413 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 150 | $35,262 | $234 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 122 | $23,163 | $97 |
| Critical care, first 30-74 minutes | 53 | $14,769 | $205 |
| Injection, regadenoson, 0.1 mg | 80 | $13,369 | None |
| Long return visit (40+ min) | 90 | $11,959 | $126 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 172 | $11,739 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 170 | $10,498 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,738 | $190 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 29 | $8,221 | $283 |
| Transitional care management services for problem of high complexity | 23 | $5,542 | $231 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 265 | $5,032 | $16 |
| New patient visit (45+ min) | 34 | $4,945 | $145 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 59 | $4,197 | $70 |
| New patient visit (60+ min) | 22 | $4,179 | $190 |
| Short return visit (20+ min) | 54 | $3,923 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 262 | $2,467 | $8 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $2,174 | $114 |
| Transitional care management services for problem of at least moderate complexity | 13 | $2,147 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 187 | $1,488 | $8 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,189 | $79 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 16 | $522 | None |
| Ultrasound of heart, follow-up | 13 | $415 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $332 | $30 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $279 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $118 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $63 | $3 |
2014: 29 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 220 | $109,988 | $498 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 219 | $57,410 | $131 |
| Return visit (30+ min) | 308 | $46,960 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 131 | $30,233 | $227 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 101 | $18,617 | $91 |
| Critical care, first 30-74 minutes | 60 | $16,634 | $193 |
| Long return visit (40+ min) | 101 | $15,452 | $125 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 221 | $14,162 | $64 |
| Injection, regadenoson, 0.1 mg | 86 | $12,036 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 31 | $8,828 | $285 |
| Transitional care management services for problem of high complexity | 33 | $7,527 | $215 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 130 | $7,465 | $57 |
| New patient visit (45+ min) | 31 | $4,430 | $143 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 229 | $4,068 | $15 |
| Short return visit (20+ min) | 64 | $4,011 | $57 |
| New patient visit (60+ min) | 15 | $2,823 | $188 |
| Transitional care management services for problem of at least moderate complexity | 16 | $2,636 | $155 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 11 | $2,598 | $236 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 36 | $2,487 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 197 | $1,681 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 218 | $1,634 | $7 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,400 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,346 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,344 | $75 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 12 | $1,318 | None |
| Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes | 11 | $246 | $16 |
| Blood test, clotting time | 15 | $79 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $36 | $3 |
| Infusion, normal saline solution, 250 cc | 14 | $3 | None |
2013: 24 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 249 | $133,633 | $520 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 253 | $67,501 | $132 |
| Return visit (30+ min) | 316 | $60,006 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 118 | $21,827 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $20,833 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 251 | $17,263 | $67 |
| Injection, regadenoson, 0.1 mg | 90 | $15,037 | None |
| Long return visit (40+ min) | 86 | $13,844 | $127 |
| Critical care, first 30-74 minutes | 50 | $11,986 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 150 | $8,479 | $55 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $6,952 | $232 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 34 | $6,710 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 271 | $5,591 | $17 |
| Extended office or other outpatient service, first hour | 57 | $5,525 | $88 |
| Short return visit (20+ min) | 54 | $3,786 | $64 |
| New patient visit (60+ min) | 19 | $3,550 | $187 |
| New patient visit (45+ min) | 24 | $3,261 | $136 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 328 | $2,792 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,321 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,841 | $88 |
| Extended inpatient or observation hospital service, first hour | 15 | $1,203 | $80 |
| Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes | 11 | $241 | $16 |
| Electrocardiogram (ecg) 2-day continuous | 11 | $240 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 11 | $188 | $17 |
Medicaid work
$29,968 in 2024
Medicaid paid $29,968 for 805 billed services this clinician did in 2024, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 310 | $23,172 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 411 | $4,359 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 46 | $1,185 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 24 | $679 |
| Return visit (30+ min) | 14 | $573 |
| 2024 | 805 | 5 | 49 | $29,968 |
| 2023 | 673 | 3 | 46 | $21,084 |
| 2022 | 763 | 3 | 76 | $16,559 |
| 2021 | 745 | 5 | 60 | $19,928 |
| 2020 | 755 | 2 | 66 | $14,905 |
| 2019 | 908 | 8 | 47 | $62,103 |
| 2018 | 285 | 4 | 23 | $19,442 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 212 | $15,976 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 392 | $3,841 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 69 | $1,267 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 116 | $9,130 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 635 | $7,229 |
| Long return visit (40+ min) | 12 | $200 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 199 | $13,157 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 489 | $4,995 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 14 | $1,495 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 24 | $251 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 19 | $30 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 125 | $8,159 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 630 | $6,746 |
2019
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 131 | $22,276 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 260 | $18,641 |
| Tc99m sestamibi | 77 | $9,760 |
| CARDIOVASCULAR STRESS TEST | 78 | $5,040 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 265 | $2,717 |
| Injection, regadenoson, 0.1 mg | 16 | $2,155 |
| Return visit (30+ min) | 44 | $949 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 37 | $566 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 183 | $14,119 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 20 | $4,215 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 28 | $566 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 54 | $542 |
Drugs they prescribed that Part D paid
$1,798,392
Pharmacies billed $1,798,392 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,481) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
6,037 generic and fewer than 11 brand-name prescriptions · $1,798,392 in drug cost · 39 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 664 | $848,459 | $1,278 |
| Entresto | 190 | $205,992 | $1,084 |
| Farxiga | 164 | $185,401 | $1,130 |
| Xarelto | 93 | $134,034 | $1,441 |
| Jardiance | 95 | $85,680 | $902 |
See all 50 drugs
| Eliquis | 664 | $848,459 | $1,278 |
| Entresto | 190 | $205,992 | $1,084 |
| Farxiga | 164 | $185,401 | $1,130 |
| Xarelto | 93 | $134,034 | $1,441 |
| Jardiance | 95 | $85,680 | $902 |
| Repatha Sureclick | 87 | $81,137 | $933 |
| Praluent | 27 | $19,995 | $741 |
| Atorvastatin | 1,145 | $15,759 | $14 |
| Dapagliflozin | 16 | $12,402 | $775 |
| Ezetimibe | 331 | $10,970 | $33 |
| Metoprolol | 579 | $8,757 | $15 |
| Clopidogrel | 306 | $5,972 | $20 |
| Diltiazem 24hr Er (Cd) | 158 | $5,490 | $35 |
| Losartan | 428 | $4,836 | $11 |
| Spironolactone | 473 | $3,999 | $8 |
| Carvedilol | 263 | $3,953 | $15 |
| Eplerenone | 37 | $3,177 | $86 |
| Amlodipine Besylate | 418 | $3,087 | $7 |
| Rosuvastatin | 182 | $2,911 | $16 |
| Irbesartan | 112 | $2,828 | $25 |
| Bisoprolol | 53 | $2,490 | $47 |
| Valsartan | 72 | $2,315 | $32 |
| Isosorbide Dinit-Hydralazine | 13 | $2,284 | $176 |
| Furosemide | 226 | $1,539 | $7 |
| Sotalol Af | 21 | $1,373 | $65 |
| Hydralazine | 74 | $1,373 | $19 |
| Isosorbide Mononitrate Er | 65 | $1,360 | $21 |
| Pantoprazole | 54 | $1,351 | $25 |
| Lisinopril | 161 | $1,332 | $8 |
| Pravastatin | 72 | $1,295 | $18 |
| Torsemide | 51 | $1,087 | $21 |
| Amiodarone | 59 | $1,037 | $18 |
| Verapamil Er | 19 | $917 | $48 |
| Cartia Xt | 12 | $806 | $67 |
| Hydrochlorothiazide | 144 | $648 | $4 |
| Diltiazem 24hr Er | 11 | $572 | $52 |
| Potassium Chloride | 33 | $491 | $15 |
| Albuterol Sulfate Hfa | 13 | $477 | $37 |
| Benazepril | 22 | $428 | $19 |
| Spironolactone-Hctz | 12 | $372 | $31 |
| Bumetanide | 16 | $360 | $23 |
| Metoprolol | 91 | $357 | $4 |
| Clonidine | 17 | $350 | $21 |
| Fenofibrate | 12 | $346 | $29 |
| Simvastatin | 45 | $291 | $6 |
| Nitroglycerin | 21 | $287 | $14 |
| Sotalol | 17 | $167 | $10 |
| Famotidine | 25 | $144 | $6 |
| Atenolol | 12 | $83 | $7 |
| Amoxicillin | 39 | $46 | $1 |
Year by year
| 2024 | 7,481 | 1,024 | 0% (0) | None | $1,798,392 |
| 2023 | 7,644 | 1,032 | 0% (0) | 19% | $1,661,911 |
| 2022 | 6,820 | 878 | 0% (0) | 17% | $1,244,108 |
| 2021 | 6,019 | 721 | None | 17% | $1,006,991 |
| 2020 | 5,727 | 691 | 0% (0) | 19% | $869,370 |
| 2019 | 5,033 | 665 | 0% (0) | 20% | $707,999 |
| 2018 | 5,193 | 613 | None | None | $659,430 |
| 2017 | 5,230 | 538 | None | None | $559,837 |
| 2016 | 5,453 | 503 | 0% (0) | None | $472,374 |
| 2015 | 5,195 | 478 | None | 22% | $378,744 |
| 2014 | 4,930 | 449 | None | 20% | $261,205 |
| 2013 | 4,490 | 427 | 0% (0) | None | $232,833 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 49 drugs
| Eliquis | 808 | $880,139 | $1,089 |
| Entresto | 181 | $172,671 | $954 |
| Xarelto | 99 | $139,016 | $1,404 |
| Farxiga | 128 | $117,534 | $918 |
| Repatha Sureclick | 58 | $55,830 | $963 |
| Praluent | 48 | $39,437 | $822 |
| Jardiance | 41 | $33,021 | $805 |
| Atorvastatin | 1,182 | $19,291 | $16 |
| Ezetimibe | 234 | $11,737 | $50 |
| Metoprolol | 593 | $11,200 | $19 |
| Clopidogrel | 325 | $8,062 | $25 |
| Losartan | 469 | $7,350 | $16 |
| Diltiazem 24hr Er (Cd) | 142 | $6,900 | $49 |
| Carvedilol | 319 | $6,026 | $19 |
| Irbesartan | 105 | $5,244 | $50 |
| Spironolactone | 385 | $4,558 | $12 |
| Rosuvastatin | 148 | $4,282 | $29 |
| Amlodipine Besylate | 472 | $4,276 | $9 |
| Eplerenone | 26 | $3,737 | $144 |
| Bisoprolol | 48 | $3,396 | $71 |
| Sotalol Af | 55 | $3,323 | $60 |
| Valsartan | 57 | $3,105 | $54 |
| Amiodarone | 52 | $3,064 | $59 |
| Isosorbide Dinitrate | 16 | $2,315 | $145 |
| Lisinopril | 158 | $2,221 | $14 |
| Furosemide | 321 | $2,161 | $7 |
| Hydralazine | 61 | $2,110 | $35 |
| Isosorbide Mononitrate Er | 62 | $1,711 | $28 |
| Verapamil Er | 24 | $1,687 | $70 |
| Pravastatin | 49 | $1,553 | $32 |
| Pantoprazole | 68 | $1,546 | $23 |
| Torsemide | 67 | $1,533 | $23 |
| Diltiazem 24hr Er | 16 | $997 | $62 |
| Benazepril | 32 | $749 | $23 |
| Bumetanide | 28 | $744 | $27 |
| Sildenafil Citrate | 15 | $630 | $42 |
| Metoprolol | 86 | $619 | $7 |
| Hydrochlorothiazide | 142 | $566 | $4 |
| Sotalol | 29 | $474 | $16 |
| Potassium Chloride | 23 | $442 | $19 |
| Olmesartan Medoxomil | 16 | $440 | $28 |
| Clonidine | 27 | $437 | $16 |
| Nitroglycerin | 22 | $401 | $18 |
| Ramipril | 15 | $324 | $22 |
| Simvastatin | 50 | $263 | $5 |
| Famotidine | 17 | $229 | $13 |
| Tamsulosin | 11 | $195 | $18 |
| Atenolol | 14 | $133 | $10 |
| Amoxicillin | 24 | $28 | $1 |
2022: 50 drugs
| Eliquis | 621 | $703,663 | $1,133 |
| Entresto | 135 | $120,112 | $890 |
| Xarelto | 92 | $115,660 | $1,257 |
| Farxiga | 55 | $38,195 | $694 |
| Repatha Sureclick | 47 | $35,007 | $745 |
| Pradaxa | 16 | $24,558 | $1,535 |
| Praluent | 39 | $23,468 | $602 |
| Atorvastatin | 1,088 | $17,256 | $16 |
| Multaq | 14 | $12,375 | $884 |
| Metoprolol | 498 | $11,421 | $23 |
| Ezetimibe | 169 | $10,616 | $63 |
| Clopidogrel | 364 | $7,665 | $21 |
| Rosuvastatin | 126 | $7,239 | $57 |
| Irbesartan | 118 | $6,907 | $59 |
| Losartan | 424 | $6,645 | $16 |
| Carvedilol | 282 | $4,986 | $18 |
| Spironolactone | 363 | $4,911 | $14 |
| Diltiazem 24hr Er (Cd) | 96 | $4,698 | $49 |
| Bisoprolol | 63 | $4,525 | $72 |
| Amlodipine Besylate | 446 | $3,166 | $7 |
| Eplerenone | 13 | $2,928 | $225 |
| Cozaar | 11 | $2,790 | $254 |
| Hydralazine | 87 | $2,773 | $32 |
| Furosemide | 312 | $2,416 | $8 |
| Isosorbide Dinitrate | 24 | $2,310 | $96 |
| Isosorbide Mononitrate Er | 80 | $2,095 | $26 |
| Valsartan | 47 | $2,062 | $44 |
| Torsemide | 76 | $1,917 | $25 |
| Sotalol Af | 22 | $1,668 | $76 |
| Flecainide Acetate | 13 | $1,644 | $126 |
| Verapamil Er | 29 | $1,610 | $56 |
| Pantoprazole | 89 | $1,609 | $18 |
| Lisinopril | 138 | $1,592 | $12 |
| Potassium Chloride | 47 | $1,566 | $33 |
| Amiodarone | 32 | $1,116 | $35 |
| Pravastatin | 52 | $1,051 | $20 |
| Metoprolol | 81 | $955 | $12 |
| Diltiazem 24hr Er | 19 | $796 | $42 |
| Bumetanide | 20 | $742 | $37 |
| Clonidine | 56 | $678 | $12 |
| Chlorthalidone | 14 | $628 | $45 |
| Simvastatin | 47 | $561 | $12 |
| Sotalol | 27 | $515 | $19 |
| Nifedipine Er | 11 | $432 | $39 |
| Hydrochlorothiazide | 106 | $403 | $4 |
| Nitroglycerin | 19 | $355 | $19 |
| Benazepril | 26 | $316 | $12 |
| Famotidine | 16 | $154 | $10 |
| Triamterene-Hydrochlorothiazid | 12 | $119 | $10 |
| Amoxicillin | 21 | $36 | $2 |
2021: 44 drugs
| Eliquis | 651 | $627,689 | $964 |
| Xarelto | 103 | $106,335 | $1,032 |
| Entresto | 65 | $45,644 | $702 |
| Pradaxa | 14 | $24,984 | $1,785 |
| Repatha Sureclick | 28 | $22,682 | $810 |
| Multaq | 21 | $22,342 | $1,064 |
| Atorvastatin | 1,039 | $17,673 | $17 |
| Metoprolol | 460 | $12,080 | $26 |
| Praluent | 22 | $11,662 | $530 |
| Ezetimibe | 152 | $7,493 | $49 |
| Losartan | 351 | $6,217 | $18 |
| Irbesartan | 120 | $6,209 | $52 |
| Bisoprolol | 75 | $5,016 | $67 |
| Diltiazem 24hr Er (Cd) | 93 | $4,727 | $51 |
| Clopidogrel | 203 | $4,549 | $22 |
| Carvedilol | 252 | $4,286 | $17 |
| Spironolactone | 312 | $4,113 | $13 |
| Eplerenone | 21 | $3,552 | $169 |
| Rosuvastatin | 112 | $3,407 | $30 |
| Torsemide | 75 | $2,916 | $39 |
| Isosorbide Mononitrate Er | 98 | $2,537 | $26 |
| Potassium Chloride | 60 | $2,426 | $40 |
| Furosemide | 259 | $2,276 | $9 |
| Amlodipine Besylate | 319 | $2,252 | $7 |
| Lisinopril | 186 | $1,877 | $10 |
| Verapamil Er | 27 | $1,663 | $62 |
| Valsartan | 35 | $1,501 | $43 |
| Amiodarone | 55 | $1,431 | $26 |
| Hydralazine | 36 | $1,308 | $36 |
| Pravastatin | 51 | $1,293 | $25 |
| Pantoprazole | 54 | $1,034 | $19 |
| Sotalol | 28 | $983 | $35 |
| Spironolactone-Hctz | 12 | $775 | $65 |
| Metoprolol | 66 | $661 | $10 |
| Bumetanide | 16 | $654 | $41 |
| Hydrochlorothiazide | 120 | $568 | $5 |
| Simvastatin | 51 | $492 | $10 |
| Benazepril | 32 | $414 | $13 |
| Clonidine | 29 | $411 | $14 |
| Nitroglycerin | 18 | $362 | $20 |
| Famotidine | 13 | $291 | $22 |
| Lisinopril-Hydrochlorothiazide | 11 | $145 | $13 |
| Tamsulosin | 13 | $64 | $5 |
| Amoxicillin | 13 | $18 | $1 |
2020: 50 drugs
| Eliquis | 653 | $550,508 | $843 |
| Xarelto | 88 | $85,865 | $976 |
| Pradaxa | 17 | $24,480 | $1,440 |
| Praluent | 22 | $18,737 | $852 |
| Atorvastatin | 869 | $18,216 | $21 |
| Metoprolol | 464 | $16,424 | $35 |
| Repatha Sureclick | 18 | $14,262 | $792 |
| Entresto | 18 | $14,066 | $781 |
| Ezetimibe | 118 | $8,006 | $68 |
| Irbesartan | 130 | $6,576 | $51 |
| Losartan | 366 | $5,751 | $16 |
| Eplerenone | 21 | $5,040 | $240 |
| Diltiazem 24hr Er (Cd) | 86 | $4,983 | $58 |
| Bisoprolol | 70 | $4,858 | $69 |
| Ranolazine Er | 12 | $4,493 | $374 |
| Spironolactone | 349 | $4,229 | $12 |
| Rosuvastatin | 92 | $3,491 | $38 |
| Carvedilol | 219 | $3,328 | $15 |
| Potassium Chloride | 49 | $3,066 | $63 |
| Clopidogrel | 154 | $2,898 | $19 |
| Torsemide | 72 | $2,630 | $37 |
| Amlodipine Besylate | 359 | $2,489 | $7 |
| Lisinopril | 211 | $2,134 | $10 |
| Furosemide | 239 | $2,077 | $9 |
| Pravastatin | 62 | $1,951 | $31 |
| Isosorbide Mononitrate Er | 66 | $1,867 | $28 |
| Valsartan | 35 | $1,858 | $53 |
| Aldactone | 11 | $1,793 | $163 |
| Verapamil Er | 26 | $1,437 | $55 |
| Amiodarone | 59 | $1,328 | $23 |
| Sotalol | 26 | $1,312 | $50 |
| Spironolactone-Hctz | 17 | $991 | $58 |
| Cartia Xt | 19 | $794 | $42 |
| Hydrochlorothiazide | 122 | $700 | $6 |
| Pantoprazole | 35 | $690 | $20 |
| Enalapril Maleate | 14 | $676 | $48 |
| Simvastatin | 64 | $654 | $10 |
| Diltiazem 24hr Er | 17 | $569 | $33 |
| Hydralazine | 23 | $507 | $22 |
| Clonidine | 21 | $487 | $23 |
| Levothyroxine | 15 | $470 | $31 |
| Dilt-Xr | 12 | $458 | $38 |
| Fludrocortisone Acetate | 11 | $421 | $38 |
| Metoprolol | 48 | $400 | $8 |
| Nitroglycerin | 24 | $390 | $16 |
| Benazepril | 32 | $357 | $11 |
| Lovastatin | 13 | $283 | $22 |
| Omeprazole | 22 | $191 | $9 |
| Famotidine | 14 | $136 | $10 |
| Amoxicillin | 17 | $30 | $2 |
2019: 53 drugs
| Eliquis | 575 | $432,132 | $752 |
| Xarelto | 68 | $59,304 | $872 |
| Praluent | 26 | $35,288 | $1,357 |
| Pradaxa | 17 | $21,176 | $1,246 |
| Atorvastatin | 743 | $16,259 | $22 |
| Metoprolol | 355 | $14,457 | $41 |
| Dofetilide | 16 | $7,546 | $472 |
| Entresto | 16 | $7,133 | $446 |
| Ezetimibe | 101 | $6,836 | $68 |
| Irbesartan | 114 | $5,144 | $45 |
| Ranolazine Er | 23 | $4,987 | $217 |
| Rosuvastatin | 85 | $4,584 | $54 |
| Losartan | 292 | $3,662 | $13 |
| Diltiazem 24hr Er (Cd) | 63 | $3,465 | $55 |
| Eplerenone | 17 | $3,224 | $190 |
| Carvedilol | 231 | $2,922 | $13 |
| Spironolactone | 259 | $2,702 | $10 |
| Flecainide Acetate | 26 | $2,545 | $98 |
| Amlodipine Besylate | 321 | $2,385 | $7 |
| Lisinopril | 221 | $2,199 | $10 |
| Bisoprolol | 32 | $2,088 | $65 |
| Amiodarone | 44 | $2,034 | $46 |
| Potassium Chloride | 37 | $2,033 | $55 |
| Torsemide | 52 | $1,979 | $38 |
| Isosorbide Mononitrate Er | 49 | $1,810 | $37 |
| Furosemide | 202 | $1,794 | $9 |
| Cozaar | 11 | $1,691 | $154 |
| Isosorbide Dinitrate | 13 | $1,569 | $121 |
| Cartia Xt | 34 | $1,507 | $44 |
| Valsartan | 32 | $1,446 | $45 |
| Spironolactone-Hctz | 31 | $1,390 | $45 |
| Clopidogrel | 79 | $1,312 | $17 |
| Pravastatin | 42 | $1,308 | $31 |
| Verapamil Er | 27 | $1,134 | $42 |
| Sotalol | 23 | $931 | $40 |
| Enalapril Maleate | 14 | $834 | $60 |
| Simvastatin | 88 | $780 | $9 |
| Sotalol Af | 11 | $712 | $65 |
| Hydralazine | 26 | $660 | $25 |
| Nitroglycerin | 23 | $598 | $26 |
| Digoxin | 16 | $575 | $36 |
| Omeprazole | 22 | $543 | $25 |
| Hydrochlorothiazide | 104 | $534 | $5 |
| Metoprolol | 64 | $454 | $7 |
| Finasteride | 15 | $395 | $26 |
| Benazepril | 29 | $279 | $10 |
| Clonidine | 22 | $225 | $10 |
| Lovastatin | 15 | $190 | $13 |
| Losartan-Hydrochlorothiazide | 12 | $186 | $16 |
| Pantoprazole | 13 | $186 | $14 |
| Levothyroxine | 13 | $168 | $13 |
| Triamterene-Hydrochlorothiazid | 16 | $113 | $7 |
| Amoxicillin | 11 | $13 | $1 |
2018: 55 drugs
| Eliquis | 614 | $398,743 | $649 |
| Praluent | 40 | $47,921 | $1,198 |
| Xarelto | 53 | $39,583 | $747 |
| Atorvastatin | 749 | $16,581 | $22 |
| Ezetimibe | 84 | $13,282 | $158 |
| Pradaxa | 15 | $13,269 | $885 |
| Dofetilide | 23 | $12,753 | $554 |
| Metoprolol | 361 | $12,624 | $35 |
| Ranexa | 12 | $9,738 | $812 |
| Irbesartan | 151 | $4,147 | $27 |
| Torsemide | 109 | $3,676 | $34 |
| Uloric | 11 | $3,514 | $319 |
| Losartan | 265 | $3,313 | $13 |
| Potassium Chloride | 51 | $2,847 | $56 |
| Spironolactone | 301 | $2,805 | $9 |
| Amiodarone | 70 | $2,596 | $37 |
| Carvedilol | 218 | $2,587 | $12 |
| Valsartan | 47 | $2,237 | $48 |
| Diltiazem 24hr Er (Cd) | 64 | $2,204 | $34 |
| Amlodipine Besylate | 292 | $2,190 | $7 |
| Isosorbide Mononitrate Er | 43 | $2,075 | $48 |
| Verapamil Er | 51 | $1,963 | $38 |
| Bisoprolol | 40 | $1,953 | $49 |
| Isosorbide Dinitrate | 16 | $1,918 | $120 |
| Pravastatin | 56 | $1,905 | $34 |
| Flecainide Acetate | 17 | $1,757 | $103 |
| Eplerenone | 11 | $1,745 | $159 |
| Cartia Xt | 62 | $1,710 | $28 |
| Rosuvastatin | 58 | $1,695 | $29 |
| Lisinopril | 157 | $1,263 | $8 |
| Furosemide | 211 | $1,203 | $6 |
| Digoxin | 41 | $1,195 | $29 |
| Midodrine | 14 | $1,137 | $81 |
| Lasix | 12 | $1,114 | $93 |
| Clopidogrel | 80 | $1,089 | $14 |
| Spironolactone-Hctz | 23 | $1,075 | $47 |
| Hydralazine | 49 | $918 | $19 |
| Sotalol Af | 15 | $731 | $49 |
| Chlorthalidone | 13 | $723 | $56 |
| Simvastatin | 89 | $720 | $8 |
| Diltiazem 24hr Er | 12 | $688 | $57 |
| Sotalol | 30 | $663 | $22 |
| Metoprolol | 50 | $524 | $10 |
| Nitroglycerin | 14 | $488 | $35 |
| Omeprazole | 24 | $445 | $19 |
| Hydrochlorothiazide | 83 | $441 | $5 |
| Fludrocortisone Acetate | 12 | $387 | $32 |
| Pantoprazole | 16 | $317 | $20 |
| Finasteride | 16 | $300 | $19 |
| Levothyroxine | 17 | $267 | $16 |
| Clonidine | 28 | $255 | $9 |
| Benazepril | 25 | $215 | $9 |
| Warfarin | 20 | $214 | $11 |
| Lovastatin | 14 | $173 | $12 |
| Clindamycin | 13 | $20 | $2 |
2017: 55 drugs
| Eliquis | 569 | $302,387 | $531 |
| Xarelto | 83 | $45,806 | $552 |
| Praluent | 26 | $30,562 | $1,175 |
| Dofetilide | 14 | $17,465 | $1,247 |
| Ranexa | 24 | $14,909 | $621 |
| Zetia | 25 | $13,713 | $549 |
| Atorvastatin | 711 | $13,572 | $19 |
| Ezetimibe | 54 | $10,821 | $200 |
| Metoprolol | 287 | $10,692 | $37 |
| Crestor | 15 | $6,715 | $448 |
| Pradaxa | 14 | $5,280 | $377 |
| Potassium Chloride | 85 | $3,951 | $46 |
| Uloric | 12 | $3,618 | $301 |
| Torsemide | 125 | $3,539 | $28 |
| Irbesartan | 129 | $3,393 | $26 |
| Verapamil | 11 | $2,935 | $267 |
| Valsartan | 56 | $2,805 | $50 |
| Losartan | 286 | $2,677 | $9 |
| Verapamil Er | 80 | $2,495 | $31 |
| Isosorbide Mononitrate Er | 64 | $2,431 | $38 |
| Carvedilol | 251 | $2,400 | $10 |
| Rosuvastatin | 59 | $2,285 | $39 |
| Bisoprolol | 46 | $2,275 | $49 |
| Diltiazem 24hr Er | 78 | $2,237 | $29 |
| Amlodipine Besylate | 325 | $2,095 | $6 |
| Spironolactone | 227 | $2,080 | $9 |
| Pravastatin | 50 | $1,775 | $35 |
| Flecainide Acetate | 27 | $1,651 | $61 |
| Aldactone | 12 | $1,605 | $134 |
| Isosorbide Dinitrate | 14 | $1,485 | $106 |
| Clopidogrel | 111 | $1,406 | $13 |
| Sotalol Af | 25 | $1,405 | $56 |
| Lisinopril | 209 | $1,284 | $6 |
| Furosemide | 251 | $1,249 | $5 |
| Digoxin | 33 | $1,108 | $34 |
| Lasix | 12 | $1,040 | $87 |
| Digox | 14 | $1,019 | $73 |
| Sotalol | 28 | $916 | $33 |
| Omeprazole | 48 | $843 | $18 |
| Spironolactone-Hctz | 13 | $842 | $65 |
| Simvastatin | 97 | $791 | $8 |
| Metoprolol | 76 | $704 | $9 |
| Chlorthalidone | 13 | $689 | $53 |
| Amiodarone | 35 | $678 | $19 |
| Proair Hfa | 11 | $636 | $58 |
| Pantoprazole | 29 | $539 | $19 |
| Cartia Xt | 24 | $481 | $20 |
| Levothyroxine | 23 | $464 | $20 |
| Hydrochlorothiazide | 86 | $463 | $5 |
| Hydralazine | 30 | $450 | $15 |
| Nitroglycerin | 14 | $385 | $27 |
| Benazepril | 32 | $340 | $11 |
| Clonidine | 14 | $171 | $12 |
| Atenolol | 19 | $149 | $8 |
| Finasteride | 12 | $122 | $10 |
2016: 53 drugs
| Eliquis | 494 | $241,807 | $489 |
| Xarelto | 79 | $44,051 | $558 |
| Zetia | 55 | $29,883 | $543 |
| Crestor | 53 | $21,083 | $398 |
| Atorvastatin | 700 | $13,254 | $19 |
| Ranexa | 18 | $10,857 | $603 |
| Metoprolol | 256 | $10,008 | $39 |
| Diltiazem 24hr Er | 85 | $4,273 | $50 |
| Pradaxa | 11 | $3,870 | $352 |
| Uloric | 12 | $3,393 | $283 |
| Irbesartan | 137 | $3,255 | $24 |
| Carvedilol | 290 | $2,601 | $9 |
| Losartan | 314 | $2,584 | $8 |
| Amlodipine Besylate | 324 | $2,507 | $8 |
| Spironolactone | 250 | $2,492 | $10 |
| Lisinopril | 269 | $2,406 | $9 |
| Torsemide | 126 | $2,390 | $19 |
| Pravastatin | 72 | $2,208 | $31 |
| Eplerenone | 22 | $2,175 | $99 |
| Verapamil Er | 99 | $2,161 | $22 |
| Potassium Chloride | 86 | $2,147 | $25 |
| Verapamil | 11 | $2,137 | $194 |
| Valsartan | 35 | $1,883 | $54 |
| Furosemide | 314 | $1,713 | $5 |
| Isosorbide Mononitrate Er | 70 | $1,661 | $24 |
| Clopidogrel | 104 | $1,625 | $16 |
| Fenofibrate | 18 | $1,505 | $84 |
| Aldactone | 13 | $1,452 | $112 |
| Rosuvastatin | 15 | $1,433 | $96 |
| Bisoprolol | 31 | $1,365 | $44 |
| Simvastatin | 143 | $1,319 | $9 |
| Digox | 27 | $1,261 | $47 |
| Flecainide Acetate | 47 | $1,213 | $26 |
| Digoxin | 44 | $1,199 | $27 |
| Spironolactone-Hctz | 12 | $1,058 | $88 |
| Lasix | 12 | $969 | $81 |
| Amiodarone | 56 | $967 | $17 |
| Proair Hfa | 14 | $758 | $54 |
| Omeprazole | 55 | $751 | $14 |
| Valsartan-Hydrochlorothiazide | 11 | $662 | $60 |
| Metoprolol | 74 | $653 | $9 |
| Hydralazine | 31 | $598 | $19 |
| Chlorthalidone | 12 | $562 | $47 |
| Levothyroxine | 25 | $541 | $22 |
| Sotalol | 28 | $487 | $17 |
| Hydrochlorothiazide | 83 | $446 | $5 |
| Cartia Xt | 13 | $426 | $33 |
| Pantoprazole | 38 | $414 | $11 |
| Benazepril | 41 | $293 | $7 |
| Clonidine | 26 | $275 | $11 |
| Atenolol | 29 | $214 | $7 |
| Warfarin | 11 | $82 | $7 |
| Finasteride | 13 | $59 | $5 |
2015: 58 drugs
| Eliquis | 374 | $161,914 | $433 |
| Xarelto | 101 | $47,802 | $473 |
| Crestor | 67 | $24,881 | $371 |
| Zetia | 34 | $13,838 | $407 |
| Atorvastatin | 602 | $11,519 | $19 |
| Ranexa | 20 | $10,700 | $535 |
| Metoprolol | 251 | $10,034 | $40 |
| Diltiazem 24hr Er | 52 | $4,331 | $83 |
| Torsemide | 70 | $3,380 | $48 |
| Irbesartan | 189 | $3,352 | $18 |
| Dyrenium | 13 | $2,889 | $222 |
| Carvedilol | 311 | $2,648 | $9 |
| Pravastatin | 87 | $2,467 | $28 |
| Verapamil Er | 118 | $2,176 | $18 |
| Lisinopril | 265 | $2,104 | $8 |
| Amlodipine Besylate | 268 | $2,076 | $8 |
| Potassium Chloride | 61 | $2,065 | $34 |
| Colchicine | 12 | $1,907 | $159 |
| Losartan | 260 | $1,902 | $7 |
| Furosemide | 309 | $1,597 | $5 |
| Digox | 34 | $1,596 | $47 |
| Cartia Xt | 46 | $1,500 | $33 |
| Spironolactone | 179 | $1,442 | $8 |
| Verapamil | 14 | $1,246 | $89 |
| Valsartan | 18 | $1,244 | $69 |
| Simvastatin | 137 | $1,155 | $8 |
| Bystolic | 11 | $1,060 | $96 |
| Clopidogrel | 89 | $1,022 | $11 |
| Digoxin | 32 | $977 | $31 |
| Hydralazine | 53 | $963 | $18 |
| Flecainide Acetate | 30 | $933 | $31 |
| Proair Hfa | 18 | $931 | $52 |
| Diltiazem Er | 17 | $894 | $53 |
| Omeprazole | 59 | $881 | $15 |
| Pantoprazole | 74 | $879 | $12 |
| Amiodarone | 49 | $809 | $17 |
| Metoprolol | 94 | $763 | $8 |
| Hydrochlorothiazide | 118 | $720 | $6 |
| Valsartan-Hydrochlorothiazide | 12 | $680 | $57 |
| Chlorthalidone | 18 | $641 | $36 |
| Levothyroxine | 32 | $621 | $19 |
| Isosorbide Mononitrate Er | 35 | $590 | $17 |
| Sotalol Af | 16 | $546 | $34 |
| Sotalol | 21 | $521 | $25 |
| Bisoprolol | 21 | $502 | $24 |
| Fludrocortisone Acetate | 11 | $361 | $33 |
| Nitrostat | 19 | $311 | $16 |
| Benazepril | 37 | $299 | $8 |
| Atenolol | 37 | $276 | $7 |
| Clonidine | 39 | $270 | $7 |
| Ramipril | 11 | $222 | $20 |
| Triamterene-Hydrochlorothiazid | 11 | $197 | $18 |
| Nitroglycerin Patch | 12 | $194 | $16 |
| Losartan-Hydrochlorothiazide | 13 | $175 | $13 |
| Finasteride | 24 | $173 | $7 |
| Tamsulosin | 13 | $172 | $13 |
| Montelukast | 11 | $132 | $12 |
| Allopurinol | 16 | $64 | $4 |
2014: 54 drugs
| Eliquis | 105 | $38,632 | $368 |
| Xarelto | 78 | $36,205 | $464 |
| Crestor | 63 | $21,322 | $338 |
| Atorvastatin | 572 | $14,586 | $25 |
| Zetia | 35 | $13,091 | $374 |
| Ranexa | 16 | $11,877 | $742 |
| Metoprolol | 261 | $11,724 | $45 |
| Diovan | 30 | $10,376 | $346 |
| Irbesartan | 172 | $4,970 | $29 |
| Colcrys | 23 | $4,721 | $205 |
| Diltiazem 24hr Er | 45 | $3,545 | $79 |
| Midodrine | 12 | $3,545 | $295 |
| Carvedilol | 287 | $3,351 | $12 |
| Amlodipine Besylate | 330 | $3,269 | $10 |
| Matzim La | 12 | $3,103 | $259 |
| Losartan | 254 | $3,099 | $12 |
| Torsemide | 78 | $2,655 | $34 |
| Pravastatin | 77 | $2,322 | $30 |
| Potassium Chloride | 56 | $2,208 | $39 |
| Digox | 54 | $2,203 | $41 |
| Simvastatin | 197 | $2,151 | $11 |
| Lisinopril | 259 | $2,077 | $8 |
| Omeprazole | 87 | $1,908 | $22 |
| Diltiazem 24hr Cd | 17 | $1,730 | $102 |
| Verapamil Er | 80 | $1,671 | $21 |
| Furosemide | 334 | $1,670 | $5 |
| Clopidogrel | 56 | $1,524 | $27 |
| Digoxin | 48 | $1,468 | $31 |
| Spironolactone | 154 | $1,313 | $9 |
| Metoprolol | 120 | $1,078 | $9 |
| Pantoprazole | 61 | $1,067 | $17 |
| Flecainide Acetate | 30 | $964 | $32 |
| Isosorbide Mononitrate Er | 59 | $964 | $16 |
| Proair Hfa | 15 | $737 | $49 |
| Hydralazine | 43 | $692 | $16 |
| Hydrochlorothiazide | 139 | $659 | $5 |
| Sotalol | 17 | $656 | $39 |
| Benazepril | 42 | $599 | $14 |
| Cartia Xt | 19 | $559 | $29 |
| Bisoprolol | 16 | $547 | $34 |
| Chlorthalidone | 27 | $542 | $20 |
| Sotalol Af | 17 | $407 | $24 |
| Klor-Con 10 | 11 | $375 | $34 |
| Nitroglycerin Patch | 13 | $374 | $29 |
| Nitrostat | 24 | $370 | $15 |
| Amiodarone | 25 | $364 | $15 |
| Levothyroxine | 24 | $348 | $14 |
| Losartan-Hydrochlorothiazide | 16 | $327 | $20 |
| Atenolol | 36 | $314 | $9 |
| Metformin | 13 | $264 | $20 |
| Clonidine | 32 | $243 | $8 |
| Finasteride | 17 | $228 | $13 |
| Tamsulosin | 15 | $212 | $14 |
| Temazepam | 15 | $82 | $5 |
2013: 55 drugs
| Diovan | 116 | $29,702 | $256 |
| Atorvastatin | 475 | $19,182 | $40 |
| Xarelto | 54 | $18,324 | $339 |
| Crestor | 63 | $16,011 | $254 |
| Zetia | 56 | $14,835 | $265 |
| Multaq | 21 | $11,531 | $549 |
| Metoprolol | 213 | $10,492 | $49 |
| Diltiazem 24hr Er | 76 | $4,762 | $63 |
| Bidil | 16 | $4,681 | $293 |
| Losartan | 259 | $4,319 | $17 |
| Carvedilol | 250 | $3,990 | $16 |
| Matzim La | 12 | $3,748 | $312 |
| Colcrys | 24 | $3,729 | $155 |
| Amlodipine Besylate | 331 | $3,547 | $11 |
| Clonidine | 13 | $3,464 | $266 |
| Valsartan-Hydrochlorothiazide | 20 | $3,305 | $165 |
| Coreg Cr | 18 | $3,259 | $181 |
| Simvastatin | 248 | $3,083 | $12 |
| Diltiazem 24hr Cd | 29 | $3,072 | $106 |
| Lisinopril | 276 | $2,627 | $10 |
| Torsemide | 84 | $2,586 | $31 |
| Exforge | 11 | $2,270 | $206 |
| Omeprazole | 89 | $2,173 | $24 |
| Clopidogrel | 38 | $2,051 | $54 |
| Pravastatin | 90 | $1,947 | $22 |
| Potassium Chloride | 58 | $1,694 | $29 |
| Furosemide | 245 | $1,599 | $7 |
| Spironolactone | 140 | $1,280 | $9 |
| Metoprolol | 106 | $1,169 | $11 |
| Verapamil Er | 30 | $1,067 | $36 |
| Cartia Xt | 31 | $995 | $32 |
| Flecainide Acetate | 31 | $919 | $30 |
| Benazepril | 70 | $901 | $13 |
| Nitroglycerin Patch | 27 | $857 | $32 |
| Isosorbide Mononitrate Er | 43 | $831 | $19 |
| Sotalol | 17 | $830 | $49 |
| Irbesartan | 14 | $679 | $48 |
| Proair Hfa | 11 | $676 | $61 |
| Hydrochlorothiazide | 120 | $675 | $6 |
| Digox | 68 | $660 | $10 |
| Diltiazem Er | 16 | $623 | $39 |
| Pantoprazole | 16 | $592 | $37 |
| Ventolin Hfa | 11 | $470 | $43 |
| Chlorthalidone | 29 | $438 | $15 |
| Losartan-Hydrochlorothiazide | 13 | $371 | $29 |
| Lisinopril-Hydrochlorothiazide | 20 | $350 | $17 |
| Lovastatin | 25 | $323 | $13 |
| Atenolol | 39 | $319 | $8 |
| Triamterene-Hctz | 15 | $272 | $18 |
| Tamsulosin | 11 | $251 | $23 |
| Clonidine | 32 | $242 | $8 |
| Nitrostat | 22 | $241 | $11 |
| Sotalol Af | 12 | $215 | $18 |
| Propranolol | 11 | $78 | $7 |
| Amitriptyline | 11 | $30 | $3 |
Money from drug and device companies
$165 in 2025
| 2025 | 2 | 2 | None | $165 |
| 2023 | 2 | 2 | None | $175 |
| 2022 | 1 | 2 | None | $313 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Amgen | Meals · 2025-10-29 | Repatha | $140 |
| Heartflow | Meals · 2025-09-04 | Ffrct | $26 |
See earlier years (2023, 2022, 2020, 2019)
2023: $175
| Boston Scientific | Watchman Access System | $149 | 1 payment
|
| HeartFlow | Ffrct | $27 | 1 payment
|
2022: $313
| Medtronic | Linq II | $313 | 2 payments
|
2020: $21
| HeartFlow | None | $21 | 1 payment
|
2019: $12
| Regeneron Healthcare Solutions | Praluent | $12 | 1 payment
|
Professional record
- NPI
- 1831159607
- Licence
- CA G87722California G87722: Current · expires 2027-09-30
- Trained
- University of California, San Francisco School of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-03-24
- NPI last updated
- 2020-06-19
- NPI record certified
- 2020-06-19
This is when the NPI record was last certified, not a medical board exam.